UNSPSC 41131801: Bothrops atrox reagent

In this classification a Bothrops atrox reagent is a device made from snake venom and used to determine blood fibrinogen levels to aid in the evaluation of disseminated intravascular coagulation (non localized clotting in the blood vessels) in patients receiving heparin therapy (the administration of the anticoagulant heparin in the treatment of thrombosis) or as an aid in the classification of dysfibrinogenemia (presence in the plasma of functionally defective fibrinogen) US FDA regulates Bothrops atrox reagent under 21 CFR 864.8100 and under FDA product code JCO.

UNSPSC 41131801 Bothrops atrox reagent, a Commodity code, covers laboratory analyzers, proficiency testing samples, and consumable supplies used in clinical hematology and blood chemistry screening within state and local health systems. Recent state and local solicitations under this code reflect procurement of specialized equipment for hemoglobin analysis, custom-manufactured quality assurance samples for lab testing workflows, and replacements for ion-exchange HPLC systems and ICP-MS instrument consumables used in pediatric lead screening and hemoglobin variant detection. The issuing bodies are primarily state health and human services departments — the Texas Health and Human Services Commission (HHSC) and Department of State Health Services (DSHS) dominate recent activity — alongside higher-education institutions such as the University of Wisconsin-Madison procuring through cooperative purchasing vehicles. These solicitations reflect core clinical laboratory operations at state and regional health agencies and public universities.

Texas and Wisconsin show the most recent activity under the code. The Texas HHSC issued an IFB (HHS0017310) on May 1, 2026, for a D-10 Hemoglobin Testing System with Rack Loader to replace aging equipment at the South Texas Lab in Harlingen, with a response deadline of May 18, 2026, at 10:30 AM Central Time; evaluation is based on bidder qualifications, delivery capability, and price, with historical spend guidance of $45,050 to $80,000 for similar goods in fiscal year 2025. The University of Wisconsin-Madison solicited competitive bids for custom-made Hematology/Whole Blood Chemistry Proficiency Testing Samples via ShopUW+ (2026-UWMSN-01287-RFB) with a response deadline of April 21, 2026. A prior Texas HHSC IFB (HHS0017071) posted February 18, 2026, sought PerkinElmer ICP-MS consumables and supplies for blood lead screening, with bids due March 5, 2026, and historical spend data of $20,000 to $30,000. None of these solicitations include specific set-asides for disadvantaged enterprises, though HUB subcontracting plans are encouraged where applicable under Texas procurements.